{
  "id": 14825771,
  "title": "Cathie Wood’s ARK sells Amazon stock, buys CoreWeave and Iambic",
  "url": "https://urgent.news/2026/10/16/cathie-woods-ark-sells-amazon-stock-buys-coreweave-and-iambic",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T00:11:15.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/cathie-woods-ark-sells-amazon-stock-buys-coreweave-and-iambic-93CH-4952878"
  },
  "original_language": "en",
  "account": null,
  "summary": "On Thursday, October 15th, 2026, Cathie Wood’s ARK ETF made several significant transactions across various sectors. The most notable move was the purchase of 1,184,955 shares of Iambic Therapeutics (NASDAQ:IAM) for $18,959,280, indicating a strong interest in the biotechnology sector. ARK also increased its stake in Recursion Pharmaceuticals (NASDAQ:RXRX) by acquiring 4,230,235 shares for $15,821,078, continuing its focus on innovative biotech firms. In the tech sector, ARK bought 192,566 shares of CoreWeave (NASDAQ:CRWV) for $12,666,991, while also accumulating shares of Rocket Lab Corp (NASDAQ:RKLB) and selling shares of Amazon.com Inc. (NASDAQ:AMZN), Shopify Inc. (NYSE:SHOP), and Palantir Technologies Inc. (NYSE:PLTR). Overall, the ETF’s activity highlights a strategic reallocation towards biotechnology and innovative tech companies, while reducing exposure to select large-cap tech stocks.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}